 |
|||||
|
|||||
|
|||||
|
|||||
|
|||||
The Journal of Neuroscience, December 19, 2007, 27(51):13997-14006; doi:10.1523/JNEUROSCI.3885-07.2007
Previous Article | Next Article
Neurobiology of Disease
Inducible Alterations of Glutathione Levels in Adult Dopaminergic Midbrain Neurons Result in Nigrostriatal Degeneration
Shankar J. Chinta,1 M. J. Kumar,1 Michael Hsu,1 Subramanian Rajagopalan,1 Deepinder Kaur,1 Anand Rane,1 David G. Nicholls,1 Jinah Choi,2 andJulie K. Andersen1 1Buck Institute for Age Research, Novato, California 94945, and 2School of Natural Sciences, University of California at Merced, Merced, California 95344
Correspondence should be addressed to Prof. Julie K. Andersen, 8001 Redwood Boulevard, Novato, CA 94945. Email: jandersen{at}buckinstitute.org
Parkinson's disease is a neurodegenerative disorder characterized by the preferential loss of midbrain dopaminergic neurons in the substantia nigra (SN). One of the earliest detectable biochemical alterations that occurs in the Parkinsonian brain is a marked reduction in SN levels of total glutathione (glutathione plus glutathione disulfide), occurring before losses in mitochondrial complex I (CI) activity, striatal dopamine levels, or midbrain dopaminergic neurodegeneration associated with the disease. Previous in vitro data from our laboratory has suggested that prolonged depletion of dopaminergic glutathione results in selective impairment of mitochondrial complex I activity through a reversible thiol oxidation event. To address the effects of depletion in dopaminergic glutathione levels in vivo on the nigrostriatal system, we created genetically engineered transgenic mouse lines in which expression of
-glutamyl cysteine ligase, the rate-limiting enzyme in de novo glutathione synthesis, can be inducibly downregulated in catecholaminergic neurons, including those of the SN. A novel method for isolation of purified dopaminergic striatal synaptosomes was used to study the impact of dopaminergic glutathione depletion on mitochondrial events demonstrated previously to occur in vitro as a consequence of this alteration. Dopaminergic glutathione depletion was found to result in a selective reversible thiol-oxidation-dependent mitochondrial complex I inhibition, followed by an age-related nigrostriatal neurodegeneration. This suggests that depletion in glutathione within dopaminergic SN neurons has a direct impact on mitochondrial complex I activity via increased nitric oxide-related thiol oxidation and age-related dopaminergic SN cell loss.
Key words: glutathione; Parkinson's disease; mitochondrial complex I; dopaminergic neuron; S-nitrosation; substantia nigra
Received July 5, 2007; revised Oct. 24, 2007; accepted Oct. 25, 2007.
Correspondence should be addressed to Prof. Julie K. Andersen, 8001 Redwood Boulevard, Novato, CA 94945. Email: jandersen{at}buckinstitute.org
This article has been cited by other articles:
M. Shi, J. Bradner, T. K. Bammler, D. L. Eaton, J. Zhang, Z. Ye, A. M. Wilson, T. J. Montine, C. Pan, and J. Zhang
Identification of Glutathione S-Transferase Pi as a Protein Involved in Parkinson Disease Progression
Am. J. Pathol., July 1, 2009; 175(1): 54 - 65.
[Abstract] [Full Text] [PDF]
T. R. Hurd, R. Requejo, A. Filipovska, S. Brown, T. A. Prime, A. J. Robinson, I. M. Fearnley, and M. P. Murphy
Complex I within Oxidatively Stressed Bovine Heart Mitochondria Is Glutathionylated on Cys-531 and Cys-704 of the 75-kDa Subunit: POTENTIAL ROLE OF CYS RESIDUES IN DECREASING OXIDATIVE DAMAGE
J. Biol. Chem., September 5, 2008; 283(36): 24801 - 24815.
[Abstract] [Full Text] [PDF]
|
|
|
|
 |
|